Print

Novartis AG's Onbrez Plus Rival, Pfizer Inc. (PFE)'s Drug Boosts Lung Function  
2/10/2011 7:36:34 AM

ZURICH, Feb 10 (Reuters) - Patients with a deadly lung disease who took Novartis's (NOVN.VX) Onbrez Breezhaler as well as Pfizer's (PFE.N) Spiriva HandiHaler had better lung function than those taking only the Pfizer treatment, studies showed.
//-->